Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00094302 · ClinicalTrials.gov registry record · Phase 3
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
A Phase 3 study, sponsored by Carelon Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 3,445
- Enrollment target
NCT00094302: Completed Phase 3 study, sponsored by Carelon Research.
NCT00094302 is a Phase 3 study that has completed, run by Carelon Research. The registered enrollment target is 3,445 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (346% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00094302, a Phase 3 study, has completed, sponsored by Carelon Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 3,445 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of aldosterone antagonist therapy in reducing cardiovascular mortality, aborted cardiac arrest, and heart failure hospitalization in patients who have heart failure with preserved systolic function.
Interventions
- DRUG Placebo
- DRUG Spironolactone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,445 participants |
| Start Date | 2006-08 |
| Est. Completion | 2013-06 |
| Phase | Phase 3 |
What the finished NCT00094302 record still lists
NCT00094302 is an interventional study that assigns participants to a tested intervention. Its 3,445 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (346% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00094302 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00094302 about?
NCT00094302 is a clinical study titled "Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function". The purpose of this study is to evaluate the effectiveness of aldosterone antagonist therapy in reducing cardiovascular mortality, aborted cardiac arrest, and heart failure hospitalization in patients who have heart failure with preserved systolic function.
What is the current status of trial NCT00094302?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 3,445 participants. The study started on 2006-08. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00094302?
The interventions under investigation include: Placebo (DRUG), Spironolactone (DRUG).
Who is sponsoring clinical trial NCT00094302?
This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00094302's enrollment target sits among peer trials
3,445 70th of 2000 higher than 1,931 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03474029 · 3,400 participants · Phase 2
Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI
- NCT07142954 · 3,400 participants · Phase 3
Epidemiology and Biomarker Study in Alzheimer's Disease
- NCT00260559 · 3,500 participants
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
- NCT01612949 · 3,500 participants
Facial Analysis to Classify Difficult Intubation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia